AKKERMANSIA MUCINIPHILA WST01 (LIVE)
Product description
Akkermansia muciniphila (AKK) is recognized as a “next-generation probiotic” star strain, closely linked to body weight regulation, glucose metabolism, gut barrier integrity, and inflammation control. Both clinical and mechanistic evidence are continuously growing.
In 2025, a Cell Metabolism publication further demonstrated that the live strain WST-01 achieved significant weight loss and metabolic improvement in overweight/obese type 2 diabetes patients with low baseline AKK abundance.
AKK WST-01 (Live Strain)
Core Strengths
- Published in Cell Metabolism, the first live AKK strain in China validated by human RCT, jointly developed with top tertiary hospitals, and endorsed by an academician of the Chinese Academy of Engineering.
- Granted invention patents in 13 countries/regions worldwide.
- Achieved U.S. Self-GRAS certification.
- Weight management & blood sugar control
Read more
In 2025, a Cell Metabolism publication further demonstrated that the live strain WST-01 achieved significant weight loss and metabolic improvement in overweight/obese type 2 diabetes patients with low baseline AKK abundance.
AKK WST-01 (Live Strain)
Core Strengths
- Published in Cell Metabolism, the first live AKK strain in China validated by human RCT, jointly developed with top tertiary hospitals, and endorsed by an academician of the Chinese Academy of Engineering.
- Granted invention patents in 13 countries/regions worldwide.
- Achieved U.S. Self-GRAS certification.
- Weight management & blood sugar control
Specifications
| Categories | Fungi & Yeasts, Microorganisms & Probiotics, Mushrooms | Microorganisms & ProbioticsOther Microorganisms & Probiotics; Specialised Finished ProductsBiotic products; Digestive Health |
|---|---|
| Sales markets | Western Europe; Eastern Europe; Asia; North America; Central/South America |
| Supplied from | China |
| Certifications | Health & Safety; Sustainable Seafood |
AKKERMANSIA MUCINIPHILA WST01 (LIVE)
